NeurOptimal® Neurofeedback safety during pregnancy
NeurOptimal® Research
Neurofeedback Efficacy
Neurofeedback Uses
Neurofeedback and Psychiatric medication
NeurOptimal® Neurofeedback safety during pregnancy
There are no known contraindications to using NeurOptimal® during pregnancy.
NeurOptimal® Research
2008 Survey Report on the Use of Neuroptimal®
2014 Survey Report on the use of NeurOptimal®
NeurOptimal Research
- The American Academy of Pediatrics recognized in 2012 that the scientific literature on biofeedback (esp. EEG biofeedback or Neurofeedback) provides “Level 1, Best Support” as an evidence-based child and adolescent psychosocial intervention. The American Academy of Pediatrics “Evidence-Based Child and Adolescent Psychosocial Interventions”
- Child and Adolescent Psychiatric Clinics of North America dedicated seven out of ten chapters to Neurofeedback. The editors concluded: “EEG biofeedback meets the American Academy of Child and Adolescent Psychiatry criteria for clinical guideline (CG) for treatment of ADHD, seizure disorders, anxiety (OCD, GAD, PTSD, phobias), depression, reading disabilities, and addictive disorders. This suggests that EEG biofeedback should always be considered as an intervention for these disorders by the clinician.”
- Frank Duffy, MD, Neurologist, Head of the Neuroimaging Department and of Neuroimaging Research at Boston Children’s Hospital, and Harvard Medical School Professor, conducted a review of the literature on neurofeedback, Duffy F, Editorial, Clinical EEG,31,(1), 2000. He summarized his findings: “The literature, which lacks any negative study of substance, suggests that EEG biofeedback therapy should play a major therapeutic role in many difficult areas. In my opinion, if any medication had demonstrated such a wide spectrum of efficacy, it would be universally accepted and widely used.”
- Dr. Katie Campbell-Daley, staff of the Department of Medicine, Children’s Hospital Boston and in the Department of Pediatrics of the Harvard Medical School reviewed the research and practice standards on treatment of ADHD and concluded in a recent paper published in Current Opinion in Pediatrics: “Overall, these findings support the use of multi-modal treatment, including medication, parent/school counseling, and EEG biofeedback, in the long term management of ADHD, with EEG biofeedback in particular providing a sustained effect even without stimulant treatment…. The therapy most promising by recent clinical trials appears to be EEG biofeedback.” Daley, Katie Campbell. “Update on Attention-deficit/hyperactivity Disorder.” Current Opinion in Pediatrics 16.2 (2004): 217-26. Print.
- Duric, Nezla S., Assmus, Jorg, Gundersen, Doris, and Elgen, Irene B. “Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports.” BMC Psychiatry; 12:107, published 10 August 2012; available at http://www.biomedcentral.com/1471-244X/12/107 Conclusions: Neurofeedback was as effective as Ritalin.
Neurofeedback Uses
Optimal functioning for any person, including peak performance for artists, athletes, meditators, musicians and other performers, spiritual development, students, and for police, fire and military personnel, without a psychiatric record. Neurofeedback can help with many conditions including, stress, anxiety, acute stress disorder (ASD), post-traumatic stress disorder (PTSD), depression, bipolar disorder, schizophrenia, personality disorders, obsessive-compulsive disorder (OCD), sleep disorders, ADD and ADHD, autism and Asperger’s syndrome, attachment and developmental disorders, fibromyalgia and other pain disorders, migraines and other headaches, post-concussion syndrome and traumatic brain injury, seizure disorders, post-stroke, cerebral palsy, intellectual and learning disabilities, age related cognitive decline, Alzheimers disease, and many others.
Neurofeedback and Psychiatric medication
Neurofeedback can provide relief to some who might otherwise choose to suffer without, or require, psychiatric medication, provide additional benefit to those on medication, or when possible, allow medication to be reduced or eliminated.